In animal models, the upregulation of JAM-A in different organs, including the kidneys, has been shown to trigger stable elevations in blood pressure, possibly suggesting a pathogenic role for JAM-A in arterial hypertension (Xu et al., 2012). This evidence concerns the gene F11R and Hypertension.